Schedule 13G ownership disclosure
PHASEBIO PHARMACEUTICALS INC
Security class unavailable · CUSIP: 717224109
Event date: 2019-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,607,044
- Percent of class
- 5.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000904454-20-000049
- Form type
- SC 13G
- Filer
- JOHNSON & JOHNSON
- CIK
- CIK 200406
- Filed
- Jan 17, 2020
- Reporting period
- Dec 31, 2019
- Description
- Schedule 13G beneficial ownership